Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Malaria Journal|September 1, 2016
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in BandiagaraMahamadou A Thera, Drissa Coulibaly, Abdoulaye K Kone, et al.
Antibiotics (Basel, Switzerland)|November 27, 2025
Antimicrobial Consumption and Utilisation in Zambia: Results from the Analysis of National Data for the Human and Animal Health SectorsSteward Mudenda, Joseph Yamweka Chizimu, Victor Daka, et al.
Pathogens (Basel, Switzerland)|June 26, 2024
Detection of Human Adenovirus and Rotavirus in Wastewater in Lusaka, Zambia: Demonstrating the Utility of Environmental Surveillance for the CommunityNgonda Saasa, Ethel M'kandawire, Joseph Ndebe, et al.
Antibiotics (Basel, Switzerland)|November 27, 2025
Antimicrobial Resistance Profiles of Bacteria Isolated from the Animal Health Sector in Zambia (2020-2024): Opportunities to Strengthen Antimicrobial Resistance Surveillance and Stewardship ProgramsTaona Sinyawa, Fusya Goma, Chikwanda Chileshe, et al.
Plos One|March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adultsCaroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
Antibiotics (Basel, Switzerland)|November 27, 2025
Impact of Multidisciplinary-Led Implementation of Antimicrobial Stewardship Programs in Zambia: Findings and ImplicationsJoseph Yamweka Chizimu, Steward Mudenda, Victor Daka, et al.
Antibiotics (Basel, Switzerland)|November 27, 2025
Diagnostic Stewardship Trends and Antimicrobial Resistance Profiles of Bacteria Isolated in Zambia: A Five-Year Retrospective Study (2020-2024)Joseph Yamweka Chizimu, Aubrey Chichonyi Kalungia, Steward Mudenda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2014
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populationsDomtila Kimani, Ya Jankey Jagne, Momodou Cox, et al.
Frontiers in Immunology|October 2, 2025
No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCTSinead Delany-Moretlwe, Hakim-Moulay Dehbi, Izukanji Sikazwe, et al.
Communications Medicine|April 17, 2026
Viral variant but not host factors associate with SARS-CoV-2 viral kineticsWilliam O Hahn, Leigh H Fisher, Amy Ward, et al.
Pageof 20